Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jpummil
    Member
    • Apr 2014
    • 85

    #1

    Canu sensitivity to genomeSize parameter

    I am currently working with some Bio faculty on a de novo assembly of Centruroides vittatus (Striped Bark Scorpion). One difficulty I seem to be having involves the command line parameter "genomeSize=" in Canu. Of course, one of the real difficulties with de novo is you likely don't know the size of the genome. You may not even have an estimate from a close relative species.

    I currently have two PacBio runs (different specimens in each) labeled Q1133 and Q1171. It seems that by varying the "genomeSize=" parameter, the output of the assembly can be significantly different! I am attaching a Quast output for some recent runs...two for each data set, with only the genomeSize parameter modified (genomeSize=170 and genomeSize=350).

    It seems that not many people have produced tools to estimate genome size in new projects that involve PacBio or ONT data...I did have some old Illumina data that was kind of iffy, but I tried the new GenomeScope tool from Schatz, et al and it comes up pretty consistently around 180Mb for an expected genome size. It was suggested to try the tool using the corrected reads out of Canu, but the tool doesn't seem to be able to evaluate that sort of input at this time.

    Any suggestions on how to best approach the problem (if it IS a problem and not simply an error on my part)? I am using essentially default values in Canu.
    Attached Files
  • rhall
    Senior Member
    • Aug 2012
    • 324

    #2
    Now that you have some contigs, why not map all your raw data to one of the assemblies and look at the coverage distribution across the contigs.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Working...